BRK-B vs RBB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
RBB Bancorp presents a complex value proposition with a stable Piotroski F-Score of 4/9 and a Graham Number of $35.54, suggesting significant defensive undervaluation. However, this is countered by a low growth-based intrinsic value of $12.81 and a bearish technical trend score of 10/100. While the company shows explosive YoY EPS growth and trades below book value (P/B 0.79), the low ROE of 6.2% and neutral insider sentiment suggest a lack of strong internal conviction. The stock is currently trading at a equilibrium point between its defensive fair value and its growth-based intrinsic value.
Compare Another Pair
Related Comparisons
BRK-B vs RBB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and RBB Bancorp (RBB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.